Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIcahn School of Medicine at Mount Sinai

About this trial

Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.

Eligibility criteria

Qualifiers

With diagnoses related to chronic lower back pain

Age above 18yrs

Non pregnant

Disqualifiers

Cancer pain

Trial design

Treatments tested in this trial

  • No Intervention

Treatment groups

130 Participants
are divided into 1 treatment group